Published March 7, 2004 | Version v1
Journal article

Dosimetry of in situ activated dysprosium microspheres

Creators

  • 1. NTI Medical Inc., Suite 1150, Manulife Place, 10180-101 Street, Edmonton, Alberta T5J 3S4 (Canada)

Description

This paper presents the results of a study aimed at investigating the dosimetry of stable dysprosium microspheres activated, in situ, by a linac generated photon beam. In phantom measurements of the neutron flux within an 18 MV photon beam were performed using CR-39 detectors and gold activation. The results were used in conjunction with a Monte Carlo computer simulation to investigate the dose distribution resulting from the activation of dysprosium (Dy) microspheres using an 18 MV photon beam. Different depths, lesion volumes and volume concentrations of microspheres are investigated. The linac lower collimator jaws are assumed completely closed to shield the tumour volume from the photon dose. Using a single AP field with 0 x 0 cm2 field size (closed jaws), a photon dose rate of 600 MU min-1 and 80 cm SSD for 10 min, an average dose exceeding 1 Gy can be delivered to spherical lesions of 0.5 cm and higher diameter. The variation of the average dose with the size of the lesion reaches saturation for tumour volumes exceeding 1 cm in diameter. This report shows that the photon beam of a high-energy linac can be used to activate Dy microspheres in situ and, as a result, deliver a significant dose of beta radiation. Non-radioactive Dy microspheres do not have the toxicity and imaging problems associated with commercially available yttrium-90 based products

Availability note (English)

Available online at http://stacks.iop.org/0031-9155/49/733/pmb4_5_006.pdf or at the Web site for the journal Physics in Medicine and Biology (ISSN 1361-6560) http://www.iop.org/

Additional details

Publishing Information

Journal Title
Physics in Medicine and Biology
Journal Volume
49
Journal Issue
5
Journal Page Range
p. 733-746
ISSN
0031-9155
CODEN
PHMBA7